An evidence-based assessment of risk factors for the progression of ocular hypertension and glaucoma

David S Friedman, M. Roy Wilson, Jeffrey M. Liebmann, Robert D. Fechtner, Robert N. Weinreb

Research output: Contribution to journalArticle

Abstract

Purpose To critically review the existing literature concerning risk factors for progression of ocular hypertension and glaucoma to assist in assigning levels of risk for individual patients. Design Evidence-based review. Methods A panel of physicians specializing in treatment of glaucoma patients was convened to critically analyze published population-based studies of ocular hypertension and glaucoma progression. The strength of evidence in support of reported risk factors was weighed. Results Many putative risk factors for progression of ocular hypertension or glaucoma have been reported in the literature. The risk factors most strongly supported by evidence are higher intraocular pressure (IOP), greater cup-to-disk ratio, thinner central corneal measurement, and older age. Black race does not appear to be an independent risk factor, although black individuals tend to have thinner corneas, greater cup-to-disk ratios, and higher IOP, which increase their risk. The limited number of studies in which other suspected risk factors are reported prevents drawing firm conclusions about their importance at this time. Conclusions Only a subset of patients with ocular hypertension will eventually develop glaucoma. Decisions regarding the implementation and extent of therapy for ocular hypertension can be difficult and require an understanding of the relative importance of risk factors for progression. This review discusses the strength of evidence supporting reported risk factors and may be useful in assessing the risk for progression of individual patients.

Original languageEnglish (US)
JournalAmerican Journal of Ophthalmology
Volume138
Issue number3 SUPPL.
DOIs
StatePublished - Sep 2004

Fingerprint

Ocular Hypertension
Glaucoma
Intraocular Pressure
Cornea
Physicians
Therapeutics

ASJC Scopus subject areas

  • Ophthalmology

Cite this

An evidence-based assessment of risk factors for the progression of ocular hypertension and glaucoma. / Friedman, David S; Wilson, M. Roy; Liebmann, Jeffrey M.; Fechtner, Robert D.; Weinreb, Robert N.

In: American Journal of Ophthalmology, Vol. 138, No. 3 SUPPL., 09.2004.

Research output: Contribution to journalArticle

Friedman, David S ; Wilson, M. Roy ; Liebmann, Jeffrey M. ; Fechtner, Robert D. ; Weinreb, Robert N. / An evidence-based assessment of risk factors for the progression of ocular hypertension and glaucoma. In: American Journal of Ophthalmology. 2004 ; Vol. 138, No. 3 SUPPL.
@article{1e03ea92fbcb4d91b11ab586098111df,
title = "An evidence-based assessment of risk factors for the progression of ocular hypertension and glaucoma",
abstract = "Purpose To critically review the existing literature concerning risk factors for progression of ocular hypertension and glaucoma to assist in assigning levels of risk for individual patients. Design Evidence-based review. Methods A panel of physicians specializing in treatment of glaucoma patients was convened to critically analyze published population-based studies of ocular hypertension and glaucoma progression. The strength of evidence in support of reported risk factors was weighed. Results Many putative risk factors for progression of ocular hypertension or glaucoma have been reported in the literature. The risk factors most strongly supported by evidence are higher intraocular pressure (IOP), greater cup-to-disk ratio, thinner central corneal measurement, and older age. Black race does not appear to be an independent risk factor, although black individuals tend to have thinner corneas, greater cup-to-disk ratios, and higher IOP, which increase their risk. The limited number of studies in which other suspected risk factors are reported prevents drawing firm conclusions about their importance at this time. Conclusions Only a subset of patients with ocular hypertension will eventually develop glaucoma. Decisions regarding the implementation and extent of therapy for ocular hypertension can be difficult and require an understanding of the relative importance of risk factors for progression. This review discusses the strength of evidence supporting reported risk factors and may be useful in assessing the risk for progression of individual patients.",
author = "Friedman, {David S} and Wilson, {M. Roy} and Liebmann, {Jeffrey M.} and Fechtner, {Robert D.} and Weinreb, {Robert N.}",
year = "2004",
month = "9",
doi = "10.1016/j.ajo.2004.04.058",
language = "English (US)",
volume = "138",
journal = "American Journal of Ophthalmology",
issn = "0002-9394",
publisher = "Elsevier USA",
number = "3 SUPPL.",

}

TY - JOUR

T1 - An evidence-based assessment of risk factors for the progression of ocular hypertension and glaucoma

AU - Friedman, David S

AU - Wilson, M. Roy

AU - Liebmann, Jeffrey M.

AU - Fechtner, Robert D.

AU - Weinreb, Robert N.

PY - 2004/9

Y1 - 2004/9

N2 - Purpose To critically review the existing literature concerning risk factors for progression of ocular hypertension and glaucoma to assist in assigning levels of risk for individual patients. Design Evidence-based review. Methods A panel of physicians specializing in treatment of glaucoma patients was convened to critically analyze published population-based studies of ocular hypertension and glaucoma progression. The strength of evidence in support of reported risk factors was weighed. Results Many putative risk factors for progression of ocular hypertension or glaucoma have been reported in the literature. The risk factors most strongly supported by evidence are higher intraocular pressure (IOP), greater cup-to-disk ratio, thinner central corneal measurement, and older age. Black race does not appear to be an independent risk factor, although black individuals tend to have thinner corneas, greater cup-to-disk ratios, and higher IOP, which increase their risk. The limited number of studies in which other suspected risk factors are reported prevents drawing firm conclusions about their importance at this time. Conclusions Only a subset of patients with ocular hypertension will eventually develop glaucoma. Decisions regarding the implementation and extent of therapy for ocular hypertension can be difficult and require an understanding of the relative importance of risk factors for progression. This review discusses the strength of evidence supporting reported risk factors and may be useful in assessing the risk for progression of individual patients.

AB - Purpose To critically review the existing literature concerning risk factors for progression of ocular hypertension and glaucoma to assist in assigning levels of risk for individual patients. Design Evidence-based review. Methods A panel of physicians specializing in treatment of glaucoma patients was convened to critically analyze published population-based studies of ocular hypertension and glaucoma progression. The strength of evidence in support of reported risk factors was weighed. Results Many putative risk factors for progression of ocular hypertension or glaucoma have been reported in the literature. The risk factors most strongly supported by evidence are higher intraocular pressure (IOP), greater cup-to-disk ratio, thinner central corneal measurement, and older age. Black race does not appear to be an independent risk factor, although black individuals tend to have thinner corneas, greater cup-to-disk ratios, and higher IOP, which increase their risk. The limited number of studies in which other suspected risk factors are reported prevents drawing firm conclusions about their importance at this time. Conclusions Only a subset of patients with ocular hypertension will eventually develop glaucoma. Decisions regarding the implementation and extent of therapy for ocular hypertension can be difficult and require an understanding of the relative importance of risk factors for progression. This review discusses the strength of evidence supporting reported risk factors and may be useful in assessing the risk for progression of individual patients.

UR - http://www.scopus.com/inward/record.url?scp=4444233602&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4444233602&partnerID=8YFLogxK

U2 - 10.1016/j.ajo.2004.04.058

DO - 10.1016/j.ajo.2004.04.058

M3 - Article

C2 - 15364049

AN - SCOPUS:4444233602

VL - 138

JO - American Journal of Ophthalmology

JF - American Journal of Ophthalmology

SN - 0002-9394

IS - 3 SUPPL.

ER -